Urtis, M.; Paganini, C.; Vilardo, V.; Tescari, A.; Minetto, S.; Cavaliere, C.; Pilotto, A.; Giorgianni, C.; Cattaneo, A.; Tagliani, M.;
et al. Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders. Genes 2025, 16, 1325.
https://doi.org/10.3390/genes16111325
AMA Style
Urtis M, Paganini C, Vilardo V, Tescari A, Minetto S, Cavaliere C, Pilotto A, Giorgianni C, Cattaneo A, Tagliani M,
et al. Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders. Genes. 2025; 16(11):1325.
https://doi.org/10.3390/genes16111325
Chicago/Turabian Style
Urtis, Mario, Chiara Paganini, Viviana Vilardo, Antonio Tescari, Samantha Minetto, Claudia Cavaliere, Andrea Pilotto, Carmela Giorgianni, Alessia Cattaneo, Marilena Tagliani,
and et al. 2025. "Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders" Genes 16, no. 11: 1325.
https://doi.org/10.3390/genes16111325
APA Style
Urtis, M., Paganini, C., Vilardo, V., Tescari, A., Minetto, S., Cavaliere, C., Pilotto, A., Giorgianni, C., Cattaneo, A., Tagliani, M., Grasso, M., Smirnova, A., Ebadi, P., Barzon, V., Favalli, V., Bimbocci, A., Baragli, M., Magi, A., Renieri, A.,
& Arbustini, E.
(2025). Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders. Genes, 16(11), 1325.
https://doi.org/10.3390/genes16111325